StockClub

IKT

IKTInhibikase Therapeutics, Inc.$ --
Inhibikase Therapeutics, Inc.

Inhibikase Therapeutics, Inc.

IKT

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-18M USD
YoY -24.8%
Net Income
-16M USD
YoY -19.8%
EPS
-0.17$
YoY -13.3%

Revenue

$0
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-16.4M
FY2024 Q2$-9.6M
$-9.6M
Q2
FY2024 Q3$-15.4M
$-15.4M
Q3
FY2024 Q4$-27.5M
$-27.5M
Q4
FY2025 Q1$-13.7M
$-13.7M
Q1
FY2025 Q2$-23.6M
$-23.6M
Q2
FY2025 Q3$-35.5M
$-35.5M
Q3
FY2025 Q4$-48.3M
$-48.3M
Q4
FY2026 Q1$-16.4M
$-16.4M
Q1
Actual
$-2.7M (-19.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$698,468
FY2020
$698,468
FY2021MISS
Actual:$3.1M
Est:$3.4M
FY2021MISS
$3.1M
FY2022BEAT
Actual:$123,440
Est:$100,000
FY2022BEAT
$123,440
FY2023BEAT
Actual:$260,500
Est:$79,570
FY2023BEAT
$260,500
FY2024IN-LINE
Actual:$0
Est:$0
FY2024IN-LINE
$0
FY2025IN-LINE
Actual:$0
Est:$0
FY2025IN-LINE
$0

Analyst Estimates